With this in mind, we replaced tyrosine 537 in the endogenous ER gene of MCF7 estrogen responsive breast cancer cells, to make serine 537, one of the most common ER mutations in advanced, metastatic breast cancer. Here, ESR1 is linked to breast cancer.